Skip to main content

. 1984 Sep;18(3):461–462. doi: 10.1111/j.1365-2125.1984.tb02491.x

A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.

G Champault, J C Patel, A M Bonnard

PMCID: PMC1463641 PMID: 6207850

461

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Carilla E., Briley M., Fauran F., Sultan C., Duvilliers C. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate. J Steroid Biochem. 1984 Jan;20(1):521–523. doi: 10.1016/0022-4731(84)90265-6. [DOI] [PubMed] [Google Scholar]
Hammond G. L. Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues. J Endocrinol. 1978 Jul;78(1):7–19. doi: 10.1677/joe.0.0780007. [DOI] [PubMed] [Google Scholar]
Koltai M., Leprán I., Nemecz G., Szekeres L. The possible mechanism of protection induced by dexamethasone against sudden death due to coronary ligation in conscious rats. Br J Pharmacol. 1983 Jun;79(2):327–329. doi: 10.1111/j.1476-5381.1983.tb11003.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Siiteri P. K., Wilson J. D. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man. J Clin Invest. 1970 Sep;49(9):1737–1745. doi: 10.1172/JCI106391. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sultan C., Terraza A., Devillier C., Carilla E., Briley M., Loire C., Descomps B. Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts. J Steroid Biochem. 1984 Jan;20(1):515–519. doi: 10.1016/0022-4731(84)90264-4. [DOI] [PubMed] [Google Scholar]
Wilson J. D. The pathogenesis of benign prostatic hyperplasia. Am J Med. 1980 May;68(5):745–756. doi: 10.1016/0002-9343(80)90267-3. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES